Microbial enhanced oil recovery (MEOR)

01Overview and value chain#

Markers EC: US EPA underground injection control | OECD: bioenergy, industrial-biotech | Regulator: EPA (USA)

Microbial enhanced oil recovery injects engineered microbial consortia and nutrients into an oil reservoir to increase the fraction of oil recoverable from an existing well, typically by reducing oil viscosity, altering rock wettability, or producing biosurfactants that mobilize trapped oil. A single treated well can see enterprise-recoverable-reserve (EUR) expansion in the double digits, as documented in recent Delaware Basin field results, without the capital cost of new drilling. MEOR is a genuine but oligopolistic field: two US firms are the commercially dominant vendors selling MEOR as a service to independent oil producers, while the rest of the reservoir-microbiology landscape is dominated by national oil companies (Petronas, Daqing, Shengli among others) running in-house programs rather than buying from commercial vendors, plus academic research that has not translated into a broader vendor market.

The key directions of microbial enhanced oil recovery are:

1. In-situ microbial injection: injecting a microbial consortium and nutrient package directly into an existing well to stimulate biosurfactant production and oil mobilization downhole.
2. Biosurfactant-mediated recovery: microbially produced surfactants that reduce interfacial tension between oil and rock, mobilizing oil trapped by capillary forces.
3. Viscosity-reduction treatments: microbial metabolic activity that reduces the viscosity of heavy or waxy crude, improving flow toward the wellbore.
4. Reservoir souring management: a related microbial-reservoir-management discipline addressing hydrogen-sulfide generation from reservoir microbial activity, distinct from but adjacent to MEOR itself.

Sectoral value chain#

[Reservoir characterization] ──> [Microbial consortium selection] ──> [Injection treatment] ──> [In-reservoir biosurfactant production]
                                                                                │
                                                                      (oil mobilization)
                                                                                │
                                                                                ▼
[Incremental oil recovery] <─── [Production monitoring] <────────────────────┘

Value chain levels#

Cross-cutting technologies of the sector:

• Reservoir microbiology assessment: characterizing a reservoir’s native microbial population and chemistry to design an effective treatment.
• Engineered microbial consortia: selecting or engineering microbial strains for biosurfactant production or viscosity reduction under specific reservoir conditions.
• Field-scale injection logistics: the operational infrastructure for delivering a microbial treatment into an active production well without disrupting operations.

02US#

The US has both confirmed dominant vendors in this oligopolistic field.

In-situ microbial injection, documented EUR expansion, biosurfactant-mediated recovery#

• Locus Bio-Energy Solutions: reported 12-month Delaware Basin field results showing a 15% EUR (estimated ultimate recovery) expansion with sustained production, confirmed via the company’s own press release and independent financial-news pickup.
• Titan Oil Recovery: an enhanced oil recovery company applying microbial technology, confirmed via a company executive’s own LinkedIn profile describing the firm’s EOR business — a weaker source than a dedicated product page, but a genuine own-employee confirmation.

03CN#

No Chinese vendor with a dedicated, confirmed commercial MEOR product was found on a live screen. This is consistent with the field’s structure: major Chinese oil producers (including Daqing and Shengli, both referenced in the broader reservoir-microbiology literature) run in-house reservoir microbiology programs rather than buying MEOR as a service from a commercial vendor.

National oil company in-house programs, no confirmed dedicated vendor#

• Market context: China’s national oil companies have documented in-house reservoir microbiology activity, but this article found no confirmed Chinese commercial vendor selling MEOR as a service comparable to the two US anchors.
• Reopen condition: if a Chinese vendor selling MEOR as a commercial service surfaces on a future screen, this section should be revised and the company added to the table.

04EU#

No EU vendor with a dedicated, confirmed commercial MEOR product was found on a live screen.

No confirmed dedicated vendor#

• Market context: this article found no EU-headquartered company with confirmed, on-topic evidence of a commercial MEOR service comparable to the two US anchors.
• Reopen condition: if an EU vendor selling MEOR as a commercial service surfaces on a future screen, this section should be revised and the company added to the table.

05Leading companies and research institutes#

06Tech stack and innovations#

The category’s technology centers on selecting and delivering a microbial treatment matched to specific reservoir chemistry, with commercial success measured directly in incremental recoverable oil volume.

1. Field-validated EUR expansion:
   • Locus Bio-Energy’s 12-month Delaware Basin results provide a documented, field-scale measurement of MEOR’s commercial impact — a 15% EUR expansion with sustained production, the kind of quantified result that differentiates a commercially proven MEOR vendor from an early-stage or academic approach.
2. Biosurfactant and viscosity-reduction mechanisms:
   • The underlying biology — microbially produced surfactants reducing oil-rock interfacial tension, or metabolic activity reducing crude viscosity — is well-established science; the commercial differentiator is field-deployment reliability and consortium engineering for specific reservoir conditions.
3. Retrofit application to existing wells:
   • MEOR’s core commercial appeal is that it applies to already-drilled wells, offering incremental production without the capital cost of new drilling — a distinct value proposition from primary or even most secondary recovery methods.

07Value chains and production pipelines#

Industrial pipeline of a MEOR field treatment (US EPA underground injection control)#

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Reservoir characterization │ ───> │ 2. Consortium selection    │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. In-reservoir activity    │ <─── │ 3. Injection treatment     │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Production monitoring    │ ───> │ 6. Incremental oil recovery │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Reservoir characterization

The target well’s reservoir conditions — temperature, salinity, oil chemistry, native microbial population — are assessed to determine MEOR suitability.

Stage 2: Consortium selection

A microbial consortium and nutrient package are selected or engineered to match the reservoir’s specific conditions and oil chemistry.

Stage 3: Injection treatment

The microbial consortium and nutrients are injected into the well through standard oilfield injection equipment.

Stage 4: In-reservoir activity

The injected microbes grow within the reservoir, producing biosurfactants or reducing oil viscosity in situ.

Stage 5: Production monitoring

Well production data is tracked over months to measure the treatment’s effect on recoverable oil volume, as in Locus Bio-Energy’s 12-month field results.

Stage 6: Incremental oil recovery

The additional oil recovered as a direct result of the microbial treatment is produced, closing the loop on the commercial return of the MEOR treatment.